Eckert & Ziegler SE (VIE:EUZG)

Market Cap	1.01B
Revenue (ttm)	304.47M
Net Income (ttm)	39.75M
Shares Out	n/a
EPS (ttm)	0.63
PE Ratio	25.44
Forward PE	18.74
Dividend	0.17 (1.12%)
Ex-Dividend Date	Jun 19, 2025

Volume	n/a
Average Volume	160
Open	15.13
Previous Close	15.07
Day's Range	14.88 - 15.13
52-Week Range	14.30 - 23.02
Beta	n/a
RSI	60.28
Earnings Date	Mar 26, 2026

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-co...

• Industry: Industrial Inorganic Chemicals
• Founded: 1992
• Employees: 1,085
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: EUZG

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.